Revolution Medicines

Senior Director, Clinical Data Management

Redwood City, California, United States · Director · Full-time

Sponsorship not specified$244k-$305kDetected 1 day ago

Machine LearningComplianceProcess ImprovementClinical TrialsClinical ResearchFDA RegulatoryResearchLeadershipCommunicationProblem Solving

About the role

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;
elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers

Lead, manage, and develop data management teams, handling resource planning, staff training, and performance reviews.
Develop and monitor KPIs for data quality and operational performance.
Manage relationships with Contract Research Organizations (CROs) and other data management vendor partners, ensuring they meet quality and performance standards.
Forecast, manage, and provide oversight for departmental budgets, including internal and external expenditures.
Serve as a key liaison and collaborate effectively with cross-functional teams (e.g., Clinical, Quality, Regulatory) and key external stakeholders.
Strong problem-solving and decision-making abilities to resolve complex issues and drive solutions.

Ensure data integrity, quality, and compliance with regulatory requirements (e.g., FDA, ICH, GCPs) and internal company policies.
Experience with global trials and regulatory submissions (FDA, EMA).
In-depth understanding of industry standards related to clinical data management (e.g., medical dictionary coding).
Guide data management activities for regulatory submissions and represent the department during regulatory inspections and internal audits.
Extensive experience in clinical data management and systems, with proven leadership experience in oncology therapeutic area.
Proficient knowledge of EDC systems (e.g., Medidata Rave), CDISC standards, and clinical trial processes.
Demonstrated ability to lead, motivate, and develop teams.

$244,000 - $305,000 USD
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

Define and implement the overall vision, strategy, and goals for the clinical data management department, including developing and enforcing departmental SOPs.
A degree in life science, health informatics, or a related field.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.